3C
CVS icon

361 Capital’s CVS Health CVS Stock Holding History

361 Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$885K Buy
+13,628
New +$858K 0.41% 73

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

361 Capital's CVS Position: Q2 2020 in Review

361 Capital opened a new position in CVS Health (CVS) in Q2 2020: 13,628 shares worth $885K. The stake represents 0.41% of the portfolio and ranks #73 among its holdings.

1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • 361 Capital held 13,628 shares of CVS Health worth $885K as of Q2 2020.
  • CVS Health was a new 361 Capital position in Q2 2020.
  • CVS Health made up 0.41% of 361 Capital's portfolio in Q2 2020, its #73 holding.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.